When should prophylactic colectomy be considered in patients with ulcerative colitis?

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 3, 2003, Pages 221-222

  Lashner, Bret A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ANTIBIOTIC THERAPY; ARTICLE; CANCER RISK; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; FECES INCONTINENCE; HUMAN; INTESTINE ANASTOMOSIS; INTESTINE FISTULA; MEDICAL DECISION MAKING; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; TREATMENT INDICATION; ULCERATIVE COLITIS;

EID: 0037366202     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.3.221     Document Type: Article

References (15)

1. Karlen P, Lofberg R, Brostrom O, Leijonmarck CE, Hellers G, Persson PG. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 1999; 94:1047-1052.
2. Wandall EP, Damkier P, Moller Pedersen F, et al. Survival and incidence of colorectal cancer in patients with ulcerative colitis in Funen County diagnosed between 1973 and 1993. Scand J Gastroenterol 2000; 35:312-317.
3. Triantafillidis JK, Manousos ON, Pomonis E, Cheracalkis P. Ulcerative colitis in Greece: clinicoepidemiological data, course, and prognostic factors in 413 consecutive patients. J Clin Gastroenterol 1998; 27:204-210.
4. Pohl C, Hombach A, Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 2000; 47:57-70.
5. Ishibashi N, Hirota Y, Ikeda M, Hirohata T. Ulcerative colitis and colorectal cancer: a follow-up study in Fukuoka, Japan. Int J Epidemiol 1999; 28:609-613.
6. Palli D, Trallori G, Saieva C, et al. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence study. Gut 1998; 42:175-179.
7. Bansal P, Sonnenberg A. Risk factors for colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 1996; 91:44-48.
8. Delco F, Sonnenberg A. Birth-cohort phenomenon in the time trends of mortality from ulcerative colitis. Am J Epidemiol 1999; 150:359-366.
9. Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA. The risk of cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999; 94:1643-1649.
10. Tung BY, Emond MJ, Haggitt RC, et al. Ursodiol is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001; 134:89-95.
11. Provenzale D, Kowdley KV, Arora S, Wong JB. Prophylactic colectomy for surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology 1995; 109:1188-1196.
12. Provenzale D, Wong JB, Onken JE, Lipscomb J. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol 1998; 93:872-880.
13. Shen B, Achkar J-P, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121:261-277.
14. Shen B, Achkar J-P, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis 2001; 7:301-305.
15. Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002; 97:972-977.